​Virid Biosciences is a privately held, research based Molecular Diagnostics company in New Jersey.  We provide customized Molecular Diagnostics Assay Development for detection of infections at Point of Care (PoC).  We provide support in developing molecular diagnostic (MDx) kits by integrating a novel, easy to use sample preparation method and integrating it with a rapid, easy to use amplification method that can be performed at Point of Care (PoC). We also provide Conventional Polymerase chain reaction (PCR), Reverse transcriptase-PCR, Real time-PCR based kits for diagnostics. We also establish and maintain, including training workforce, MDx infrastructure (laboratory) in hospitals.

Advantages of kits developed with ViridBio solutions are:

• Rapid, highly specific and sensitive identification of pathogens (including COVID-19)
• Rapid (< 5minute), simple (< 3 steps), and easy to use sample preparation method.
• Dried reagents for storage at ambient temperature.
• Total assay time of 30 minutes including sample preparation and run time, with minimal hands on time.
• A simple, easy to use device, with digital read-out and no user interpretation required.
• A technology platform that can be adapted for the detection of other targets (SARS, MERS, any future outbreak etc.).